HACE1 negatively regulates neuroinflammation through ubiquitylating and degrading Rac1 in Parkinson&

来源 :中国药理学报(英文版) | 被引量 : 0次 | 上传用户:hangxujie
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Neuroinflammation plays an important role in neurodegenerative diseases,such as Parkinson\'s disease(PD)and Alzheimer\'s disease.HACE1(HECT domain and Ankyrin repeat Containing E3 ubiquitin-protein ligase 1)is a tumor suppressor.Recent evidence suggests that HACE1 may be involved in oxidative stress responses.Due to the critical role of ROS in neuroinflammation,we speculated that HACE1 might participate in neuroinflammation and related neurodegenerative diseases,such as PD.In this study,we investigated the role of HACE1 in neuroinflammation of PD models.We showed that HACE1 knockdown exacerbated LPS-induced neuroinflammation in BV2 microglial cells in vitro through suppressing ubiquitination and degradation of activated Rac1,an NADPH oxidase subunit.Furthermore,we showed that HACE1 exerted vital neuronal protection through increasing Rac1 activity and stability in LPS-treated SH-SY5Y cells,as HACE1 knockdown leading to lower tolerance to LPS challenge.In MPTP-induced acute PD mouse model,HACE1 knockdown exacerbated motor deficits by activating Rac1.Finally,mutant α-synuclein(A53T)-overexpressing mice,a chronic PD mouse model,exhibited age-dependent reduction of HACE1 levels in the midbrain and striatum,implicating that HACE1 participated in PD pathological progression.This study for the first time demonstrates that HACE1 is a negative regulator of neuroinflammation and involved in the PD pathogenesis by regulating Rac1 activity.The data support HACE1 as a potential target for PD and other neurodegenerative diseases.
其他文献
目的:建立天龙竭胶囊HPLC指纹图谱分析方法,并同时测定红景天苷、三七皂苷R1、人参皂苷Rg1、龙血素A和龙血素B的含量.方法:采用Diamonsil C18色谱柱(250 mm×4.6 mm,5μm),以乙腈-磷酸水溶液为流动相进行梯度洗脱,检测波长203 nm,流速1 mL·min-,进样量10 μL,柱温30℃.采用HPLC法建立14批天龙竭胶囊的指纹图谱,通过相似度评价、聚类分析、主成分分析、正交偏最小二乘法判别分析及聚类热图对指纹图谱进行研究.结果:14批天龙竭胶囊的HPLC图谱有32个共有峰,
Events including antibody-antigen affinity,internalization,trafficking and lysosomal prote-olysis combinatorially determine the efficiency of antibody-drug conjugate(ADC)catabolism and hence the toxicity.Nevertheless,an approach that conveniently identifi
Although multifarious tumor-targeting modifications of nanoparticulate systems have been at-tempted in joint efforts by our predecessors,it remains challenging for nanomedicine to traverse physiolog-ical barriers involving blood vessels,tissues,and cell b
目的:探索和优化单克隆抗体电荷异构体分析的酶切预处理和高效液相色谱检测方法.方法:采用和优化基于Thermo ProPacTM WCX-10色谱柱的离子交换色谱检测方法,以含10 mmol·L-1磷酸盐和1 mol·L-1氯化钠缓冲液(pH 6.3)为流动相进行梯度洗脱,流速0.5 mL·min-1,检测信号为波长280 nm吸收度,采用免疫球蛋白G降解酶(IdeS)切前后的电荷异构体检测,并对方法的专属性、线性、重复性、精密度等指标进行考察.结果:基于阳离子交换色谱(CEX)方法和酶切处理,以几种商品化
目的:基于UPLC-MS/MS技术,研究大鼠灌胃千金子生品、霜品提取物后千金子素L1、千金子素L2和千金子素L3的尿液及粪便的排泄动力学特征.方法:SD大鼠灌胃给予千金子生品、霜品提取物,收集不同时间段的尿液和粪便,采用建立的UPLC-MS/MS方法对千金子制霜前后3个二萜醇酯类成分的浓度进行测定,以DAS 2.0软件计算尿排泄动力学参数,绘制累积排泄率及排泄速率曲线,比较制霜前后的排泄动力学差异.结果:灌胃给药千金子提取物96 h后,千金子素L1 、L2和L3在尿液中的累积排泄率分别为0.009%、0.
目的:建立药用复合膜加工助剂的残留溶剂谱,用以快速分析溶剂来源,方便指导生产工艺的改进.方法:采用气相色谱-质谱联用测定法对某企业38批药用复合膜的原辅料(油墨、溶剂、粘合剂)中的32种残留溶剂进行筛查分析,同时测定7批终产品中的残留溶剂,通过来源分析,针对性改进生产工艺,以降低溶剂残留量.结果:建立了该企业原辅料的残留溶剂谱,在终产品中找到10种残留溶剂,其中占比超过1%的溶剂有5种.分析来源并改进相关生产工艺后,溶剂残留总量明显下降.结论:建立原辅料的残留溶剂谱,有利于药用复合膜的质量控制.
目的:建立基于QuEChERS结合超高效液相色谱一串联质谱(UPLC-MS/MS)测定蜂蜜中28个吡咯里西啶生物碱的快速检测方法,并根据测定结果进行初步的风险评估.方法:采用QuEChERS法对样品进行前处理,ACQUITY UPLC HSS T3色谱柱(2.1 mm×100mm,1.8 μm),以含0.05%甲酸和2.5 mmol·L一甲酸铵的水溶液(A)及含0.05%甲酸和2.5 mmol·L-1甲酸铵的乙腈溶液(B)为流动相,梯度洗脱,流速为0.3 mL· min-1,柱温为40℃;电喷雾离子源为正
目的:建立氧化型染发产品中44种染发剂的高效液相色谱检测方法.方法:样品经无水乙醇-2g·L-1亚硫酸氢钠溶液(1∶1)超声提取后,分别采用Waters XBridge Shield RP18(250 mm ×4.6 mm,5μm)和Agilent ZORBAX SB Aq(250 mm ×4.6 mm,5μm)色谱柱进行分离,分别以甲醇-0.005 mol·L-1乙酸铵溶液(pH 7.7)、甲醇-0.005 mol·L-1磷酸二氢钾溶液(pH 7.0)为流动相,梯度洗脱,流速为1.0 mL·min-,柱
Recent evidence shows that when ischemic stroke(IS)occurs,the BBB would be destructed,thereby promoting the immune cells to migrate into the brain,suggesting that the immune responses can play a vital role in the pathology of IS.As an essential subpopulat
目的:本文借鉴准确度轮廓的研究思路,提出采用β-容度容许区间(β-CTI)建立基于不确定度轮廓(UP)的决策验证方法,并将该方法应用于大黄HPLC含量测定方法验证.方法:以芦荟大黄素、大黄酸、大黄素、大黄酚和大黄素甲醚5个成分色谱峰的分离度为优化目标,采用单因素实验对影响色谱分离效果的柱温、流动相比例等因素进行优化,确定最佳色谱分离条件.采用“3×5×4”型全析因实验设计获取HPLC验证数据,即实验分为3d进行,每天1次,每次实验包含4个浓度水平,每个浓度水平进行5次重复实验.对采集的验证数据进行方差分析